Vildagliptin 50mg Tablet
Reviewed educational reference: what Vildagliptin is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Vildagliptin
- Strength
- 50mg
- Dosage form
- Tablet
- Drug class
- Dipeptidyl peptidase-4 (DPP-4) inhibitor
Related products
No reviewed products are currently published for this generic.
Vildagliptin 50mg Tablet contains Vildagliptin, which is an oral antihyperglycemic agent belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It is indicated for the management of type 2 diabetes mellitus in adults. By inhibiting the DPP-4 enzyme, Vildagliptin increases the levels of active incretin hormones, which stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner. This helps to improve glycemic control without causing significant weight gain or increasing the risk of hypoglycemia when used as monotherapy.
At a glance
Vildagliptin 50mg Tablet contains vildagliptin, a DPP-4 inhibitor.
It helps regulate blood sugar levels by increasing incretin hormone activity.
It is used to treat type 2 diabetes mellitus in adults.
Uses of Vildagliptin
- Management of type 2 diabetes mellitus as monotherapy.
- Combination therapy with metformin for patients inadequately controlled on metformin alone.
- Combination therapy with a sulfonylurea for patients inadequately controlled on a sulfonylurea.
- Combination therapy with a thiazolidinedione for patients inadequately controlled on a thiazolidinedione.
- Triple therapy with metformin and a sulfonylurea.
- Add-on therapy to insulin in patients with inadequate glycemic control.
Benefits of Vildagliptin
Improved Glycemic Control
By enhancing the body's natural incretin system, Vildagliptin 50mg Tablet helps lower fasting and postprandial blood glucose levels. It works primarily when blood sugar is high, which minimizes the risk of low blood sugar episodes compared to older classes of diabetes medications.
Weight Neutrality and Safety
Vildagliptin 50mg Tablet is weight-neutral, meaning it does not typically cause the weight gain often associated with insulin or sulfonylureas. Furthermore, it has a low risk of hypoglycemia when used alone, making it a preferred choice for patients who need to maintain a stable weight while managing their diabetes effectively.
Side effects of Vildagliptin
While generally well-tolerated, some individuals may experience side effects while taking Vildagliptin 50mg Tablet. Common side effects include dizziness, headache, and tremors. Gastrointestinal symptoms such as nausea, abdominal pain, and constipation may also occur in some patients. In rare instances, patients have reported symptoms of upper respiratory tract infections or nasopharyngitis. More serious but rare adverse reactions include signs of liver dysfunction, such as jaundice, dark urine, or persistent nausea, and symptoms of pancreatitis, such as severe abdominal pain that may radiate to the back. If you experience persistent or severe symptoms, contact your healthcare provider immediately. Always monitor your blood glucose levels as directed to ensure the medication is working safely for your specific condition.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Nasopharyngitis | Common | Mild | Maintain good hygiene and rest. |
| Dizziness | Common | Mild | Rise slowly from sitting or lying positions. |
| Pancreatitis | Rare | Severe | Stop the medication and seek emergency care. |
How to manage side effects
Nasopharyngitis
- Monitor for worsening symptoms.
- Seek medical advice if fever develops.
- Use over-the-counter cold remedies if necessary.
Dizziness
- Avoid operating heavy machinery if dizzy.
- Ensure adequate hydration.
- Report to doctor if dizziness persists.
Pancreatitis
- Discontinue Vildagliptin 50mg Tablet immediately.
- Seek urgent medical evaluation.
- Do not restart without specialist consultation.
How to use Vildagliptin
- Take Vildagliptin 50mg Tablet exactly as prescribed by your doctor, usually once or twice daily.
- Swallow the tablet whole with a glass of water, with or without food.
- Do not crush, chew, or break the tablet unless instructed by your pharmacist.
- Maintain a consistent schedule to ensure steady levels of the medication in your blood.
- Continue your prescribed diet and exercise program alongside this medication for best results.
Special population advice
Kidney impairment
- No dose adjustment for mild impairment.
- Reduce dose to 50mg once daily for moderate or severe impairment.
Liver impairment
- Not recommended for patients with ALT or AST > 3 times the upper limit of normal.
Children
- Safety and efficacy not established; not recommended for patients under 18.
Elderly
- No dose adjustment required based on age alone; monitor renal function.
How Vildagliptin works
Vildagliptin is a potent and selective inhibitor of the DPP-4 enzyme. This enzyme is responsible for the rapid degradation of incretin hormones, specifically glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By blocking DPP-4, Vildagliptin increases the concentration of these hormones, which enhances insulin secretion from pancreatic beta cells and reduces glucagon secretion from alpha cells, thereby lowering blood glucose levels.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Vildagliptin 50mg Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time to make up for a forgotten one, as this increases the risk of side effects.
In case of overdose
In case of an overdose of Vildagliptin 50mg Tablet, seek medical attention immediately. Symptoms of overdose are not well-defined but may include severe dizziness, muscle pain, or extreme fatigue. There is no specific antidote for Vildagliptin. Treatment is generally supportive, focusing on monitoring blood glucose levels and managing any symptoms that arise. Contact your local poison control center or emergency services if you suspect an overdose.
Management is supportive and symptomatic.
- Gastric Decontamination
- Activated charcoal may be considered if ingestion was recent.
- Monitoring
- Monitor blood glucose levels frequently for 24 hours.
- Supportive Care
- Maintain hydration and manage electrolyte imbalances.
- Clinical Observation
- Observe for signs of pancreatitis or liver distress.
Safety and precautions
When to avoid Vildagliptin
- Hypersensitivity
Known allergy to vildagliptin or any excipients.
- Type 1 Diabetes
Not effective for type 1 diabetes or diabetic ketoacidosis.
- Renal impairment
Requires dose adjustment based on creatinine clearance.
- Liver disease
Monitor liver function tests regularly.
- Heart failure
Use with caution in patients with NYHA class I-II heart failure.
- Pancreatitis
Discontinue if symptoms of pancreatitis occur.
Safety at a glance
Alcohol can affect blood glucose levels and may increase the risk of hypoglycemia or liver stress.
Use is not recommended during pregnancy; consult your doctor for safer alternatives like insulin.
It is not known if this drug passes into breast milk; consult your physician before use.
Usually does not affect driving, but be cautious if you experience dizziness or tremors.
Dose adjustment may be required for patients with moderate to severe renal impairment.
Not recommended for patients with significant liver disease or elevated liver enzymes.
Do not take if you have a known hypersensitivity to vildagliptin or any component of the tablet.
Not recommended for use in children or adolescents under 18 years of age.
Generally safe, but monitor renal function periodically in elderly patients.
Interactions
With other medicines
Sulfonylureas
ModerateChanges the medicine’s effect
What can happen: Increased risk of hypoglycemia.
What to do: Consider dose reduction of the sulfonylurea.
Corticosteroids
ModerateChanges the medicine’s effect
What can happen: Reduced glucose-lowering effect.
What to do: Monitor blood glucose more frequently.
Thiazide diuretics
MinorChanges the medicine’s effect
What can happen: Potential for hyperglycemia.
What to do: Monitor glycemic control closely.
With food and drink
- High-fat mealsMinor
No significant interaction, but consistency is recommended.
- AlcoholModerate
May alter blood glucose control and increase the risk of hypoglycemia or liver stress.
If you have another condition
- Renal failure
Requires dose reduction in moderate to severe cases.
- Hepatic impairment
Not recommended for patients with active liver disease.
Effect on laboratory tests
- Liver Function Tests
Elevated enzymes
Monitor ALT/AST levels periodically during treatment.
Quick tips
- Monitor your blood sugar levels regularly as advised by your physician.
- Inform your doctor if you experience persistent nausea or severe abdominal pain.
- Keep a record of your blood glucose readings to help your doctor adjust your treatment.
- Maintain a healthy lifestyle with balanced meals and regular physical activity.
- Carry a source of fast-acting glucose, such as glucose tablets or juice, in case of unexpected hypoglycemia.
- Report any signs of infection or unusual skin rashes to your healthcare provider promptly.
Counselling points
- AdherenceImportant
Take your medication at the same time every day to maintain stable blood sugar.
- HypoglycemiaImportant
Be aware of signs like sweating, shakiness, or confusion, especially if taking other diabetes drugs.
- Liver HealthGood to know
Seek medical help if you notice yellowing of the skin or eyes, or dark urine.
- LifestyleGood to know
This drug works best when combined with a healthy diet and regular exercise.
Monitoring during treatment
Before starting
- Liver function tests (ALT, AST)
- Renal function (eGFR or creatinine clearance)
During treatment
- every 3 months: Monitor HbA1c levels to assess glycemic control.
- as needed: Liver function tests if symptoms of liver injury occur.
What is being watched
- HbA1c
- Fasting plasma glucose
- ALT/AST
- Creatinine
Pharmacokinetics
- Absorption
- Rapidly absorbed after oral administration.
- Bioavailability
- Approximately 85%.
- Protein binding
- Low (9.3%).
- Volume of distribution
- 71 liters.
- Half-life
- Approximately 3 hours.
- Metabolism
- Primarily hydrolyzed to inactive metabolites.
- Excretion
- Renal (85%) and fecal (15%).
- Onset / duration
- Rapid onset; effect lasts for 24 hours.
Fact box
- Chemical class
- Adamantyl-glycine derivative
- Habit forming
- No
- Therapeutic class
- Antidiabetic agent
- Action class
- Incretin enhancer
- Storage
- Store Vildagliptin 50mg Tablet in a cool, dry place below 30°C. Keep the medication in its original packaging to protect it from moisture and light. Keep out of reach of children.
- ATC code
- A10BH02
- Pregnancy category
- Category B
More information
Clinical Rationale for DPP-4 Inhibitors
Clinicians often select Vildagliptin as a second-line therapy because of its favorable safety profile and ease of use. Unlike sulfonylureas, which stimulate insulin secretion regardless of blood glucose levels, Vildagliptin acts in a glucose-dependent manner. This means the risk of hypoglycemia is significantly lower. Furthermore, it does not cause the weight gain associated with thiazolidinediones or insulin, making it an attractive option for patients who are overweight or concerned about body image. Its once-daily or twice-daily dosing regimen also improves patient adherence compared to more complex insulin-based regimens.
Comparison with Other Antidiabetic Agents
When compared to metformin, Vildagliptin is generally less potent in lowering HbA1c but is often better tolerated by patients who experience gastrointestinal side effects with metformin. Compared to SGLT2 inhibitors, Vildagliptin does not carry the risk of genital mycotic infections or volume depletion. While it lacks the cardiovascular benefits demonstrated by some SGLT2 inhibitors and GLP-1 receptor agonists, it remains a reliable, cost-effective, and well-tolerated choice for patients who have achieved partial control with metformin but require additional glycemic lowering without the burden of weight gain or frequent hypoglycemia.
Lifestyle and Dietary Considerations
Taking Vildagliptin 50mg Tablet does not eliminate the need for a structured diabetes management plan. Patients should focus on a diet rich in fiber, whole grains, and lean proteins while limiting refined sugars and saturated fats. Regular physical activity, such as brisk walking for 30 minutes a day, helps improve insulin sensitivity and complements the pharmacological action of Vildagliptin. It is also important to stay hydrated and monitor blood glucose levels consistently, as lifestyle changes can lead to rapid improvements in glycemic control that may necessitate a dose adjustment by the physician.
Managing Expectations During Treatment
Patients starting Vildagliptin 50mg Tablet should understand that it is not a cure for diabetes but a tool for long-term management. Initial results may not be immediate; it often takes several weeks to see the full effect on HbA1c levels. During the first few months, your doctor will likely monitor your liver enzymes and renal function to ensure the medication is safe for you. If you experience any unusual symptoms, such as persistent abdominal pain or signs of an allergic reaction, do not wait for your next appointment. Open communication with your healthcare team is essential for optimizing your treatment plan and preventing long-term complications of diabetes.
References
- Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed
- Electronic Medicines Compendium. Vildagliptin 50mg Tablets, Summary of Product Characteristics.View sourceAccessed
- European Medicines Agency. Galvus (vildagliptin) Product Information.View sourceAccessed
- Pharmacy and Poisons Board Kenya. Vildaril M 850mg Tablets, Summary of Product Characteristics.View sourceAccessed
- National Agency for Food and Drug Administration and Control. Vildagliptin SmPC.View sourceAccessed
Frequently asked questions about Vildagliptin
Can I take Vildagliptin 50mg Tablet on an empty stomach?
Yes, Vildagliptin 50mg Tablet can be taken with or without food as it does not significantly affect its absorption.
Does Vildagliptin 50mg Tablet cause weight gain?
No, Vildagliptin 50mg Tablet is considered weight-neutral and is not associated with weight gain.
How long does it take for Vildagliptin 50mg Tablet to work?
You may notice improvements in blood glucose levels within a few days, but full therapeutic effect is typically observed after a few weeks of consistent use.
Is Vildagliptin 50mg Tablet the same as insulin?
No, Vildagliptin 50mg Tablet is an oral tablet that helps your body produce its own insulin more effectively, whereas insulin is a hormone replacement therapy.
What should I do if I feel sick after taking the tablet?
If you experience persistent nausea or vomiting, contact your doctor to rule out other causes or potential side effects.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →